Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now includes Data sharing and IPD Plan sections detailing data-access policies and related documents, and the previous revision tag 'Revision: v3.6.4' was removed.
    Difference
    100%
    Check dated 2026-08-11T17:50:30.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Deleted entries in the Study Documents section that provided access to major trial documents (Statistical Analysis Plan, Study Protocol) and the data-sharing/IPD information, reducing availability of key methodological and transparency resources for the DREAMM-3 trial.
    Difference
    16%
    Check dated 2026-08-04T16:07:55.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4. This indicates a minor update/patch to the page’s metadata.
    Difference
    0.0%
    Check dated 2026-07-21T13:23:07.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now lists 136 investigational sites across various countries and updates trial durations/outcome timeframes (e.g., weeks-based horizons), reflecting the current scope of the DREAMM-3 study.
    Difference
    4%
    Check dated 2026-07-07T06:22:31.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page's related topics were expanded to include Multiple myeloma and MedlinePlus Genetics, and the site revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T01:24:49.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now indicates the study is no longer recruiting participants, clarifying current enrollment status. Additionally, new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added and the Intervention/Treatment label was reformatted.
    Difference
    0.3%
    Check dated 2026-06-15T19:21:27.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.